PHARMATHENE INC's ticker is PIP and the CUSIP is 71714G102. A total of 42 filers reported holding PHARMATHENE INC in Q1 2014. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $738,000 | -75.5% | 909,132 | -1.9% | 0.00% | – |
| Q4 2016 | $3,013,000 | +35.9% | 926,856 | +21.4% | 0.00% | – |
| Q3 2016 | $2,217,000 | +55.4% | 763,658 | +30.7% | 0.00% | – |
| Q2 2016 | $1,427,000 | +4359.4% | 584,477 | +3399.9% | 0.00% | – |
| Q1 2016 | $32,000 | 0.0% | 16,700 | 0.0% | 0.00% | – |
| Q4 2015 | $32,000 | +45.5% | 16,700 | 0.0% | 0.00% | – |
| Q3 2015 | $22,000 | -29.0% | 16,700 | 0.0% | 0.00% | – |
| Q2 2015 | $31,000 | +19.2% | 16,700 | 0.0% | 0.00% | – |
| Q1 2015 | $26,000 | -16.1% | 16,700 | 0.0% | 0.00% | – |
| Q4 2014 | $31,000 | -8.8% | 16,700 | -10.2% | 0.00% | – |
| Q3 2014 | $34,000 | +30.8% | 18,600 | 0.0% | 0.00% | – |
| Q2 2014 | $26,000 | -23.5% | 18,600 | 0.0% | 0.00% | – |
| Q1 2014 | $34,000 | -39.3% | 18,600 | -50.0% | 0.00% | – |
| Q4 2013 | $56,000 | +43.6% | 37,200 | +100.0% | 0.00% | – |
| Q3 2013 | $39,000 | +34.5% | 18,600 | 0.0% | 0.00% | – |
| Q2 2013 | $29,000 | – | 18,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 520,000 | $422,000 | 0.44% |
| FIRST QUADRANT LLC/CA | 1,655,539 | $1,343,000 | 0.03% |
| OXFORD ASSET MANAGEMENT LLP | 1,118,005 | $907,000 | 0.02% |
| CIGNA INVESTMENTS INC /NEW | 303,239 | $246,000 | 0.02% |
| Burt Wealth Advisors | 17,870 | $15,000 | 0.01% |
| Sullivan, Bruyette, Speros & Blaney, LLC | 126,346 | $103,000 | 0.01% |
| ClariVest Asset Management LLC | 322,970 | $262,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 594,444 | $482,000 | 0.01% |
| Renaissance Technologies | 4,790,931 | $3,888,000 | 0.01% |
| Mraz, Amerine & Associates, Inc. | 20,000 | $15,000 | 0.01% |